Monsenso A/S

Monsenso A/S AAQS

The The AAQS of Monsenso A/S (MONSO.CO) as of Oct 23, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).

AAQS

4

YoY

0.00%

Last updated:

Monsenso A/S has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Monsenso A/S in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Monsenso A/S AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
4.00 DKK
Jan 1, 2019
4.00 DKK
Jan 1, 2020
4.00 DKK
Jan 1, 2021
4.00 DKK
Jan 1, 2022
4.00 DKK
Jan 1, 2023
4.00 DKK
Jan 1, 2024
4.00 DKK
Jan 1, 2025
4.00 DKK
The Monsenso A/S AAQS history
YEARAAQSYoY
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Monsenso A/S Stock analysis

What does Monsenso A/S do? Monsenso A/S develops SaaS cloud solutions that connect individuals with mental disorders and their caregivers to clinicians for enhanced data collection, collaboration, and communication. The company's platform supports health prevention, early intervention, and treatment of psychological disorders through its cloud-based service. Clinicians such as therapists and physicians use the platform to interact with patients and their relatives or caregivers. The primary customers are healthcare providers and mental health institutions seeking to improve patient outcomes through digital tools. The company generates revenue by offering its SaaS solution as a subscription service to healthcare organizations. The platform enables continuous data collection and communication between patients, caregivers, and clinicians, which is essential for mental health treatment. Healthcare providers purchase the service to integrate it into their existing workflows for better patient management. Monsenso A/S targets mental health treatment providers and institutions focused on psychological disorders. Its solution is designed to support early intervention and long-term management of mental health conditions through regular data exchange. The service is used by clinicians to monitor patient progress and adjust treatments based on real-time information gathered from the platform. Monsenso A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Monsenso A/S stock

The AAQS of Monsenso A/S is 4 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Monsenso A/S since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Monsenso A/S

All Key Metrics — Monsenso A/S